Biomodulatory therapy induces complete molecular remission in chemorefractory acute myeloid leukemia

Haematologica. 2015 Jan;100(1):e4-6. doi: 10.3324/haematol.2014.115055. Epub 2014 Sep 26.
No abstract available

Keywords: 5-azacytidine; ATRA; acute myeloid leukemia; biomodulatory therapy; pioglitazone.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antimetabolites, Antineoplastic / therapeutic use
  • Antineoplastic Agents / therapeutic use
  • Azacitidine / therapeutic use*
  • Drug Resistance, Neoplasm / drug effects*
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Leukemia, Myeloid, Acute / drug therapy*
  • Leukemia, Myeloid, Acute / mortality
  • Leukemia, Myeloid, Acute / pathology
  • Male
  • Middle Aged
  • Neoplasm Grading
  • Neoplasm Staging
  • Pioglitazone
  • Prognosis
  • Remission Induction
  • Salvage Therapy*
  • Survival Rate
  • Thiazolidinediones / therapeutic use*
  • Tretinoin / therapeutic use*

Substances

  • Antimetabolites, Antineoplastic
  • Antineoplastic Agents
  • Hypoglycemic Agents
  • Thiazolidinediones
  • Tretinoin
  • Azacitidine
  • Pioglitazone